<DOC>
	<DOCNO>NCT02274207</DOCNO>
	<brief_summary>The purpose study test therapeutic benefit silver dress compare non-silver dressing NPWT ( Negative pressure wound therapy ) . Silver dressing may antibacterial effect infect diabetes mellitus foot .</brief_summary>
	<brief_title>Comparative Study Antibacterial Effect Silver Dressing Negative Pressure Wound</brief_title>
	<detailed_description>Investigator recruit sixty patient . Participant randomly assign one two group . One use silver dress group NPWT , another use non-silver dress group NPWT . Participant visit screen day , NPWT apply day F/u day 4 month . Investigators conduct check wound base , Lab , wound culture .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<criteria>The patient 20 year type I , II diabetes mellitus foot ulcer Infected ulcer one . 1. clinically infection symptom ulcer area : warmth , erythema , tenderness/swelling induration , purulent discharge etc . 2 . Confirmed case bacteria wound culture . 3 . Conformed case abnormal range erythrocyte sedimentation rate ( ESR ) /Creactive protein ( CRP ) level lab . Has apply NPWT suture impossible ulcer area . The patient voluntary agree protocol . In opinion investigator , It suitable participate study . Infection bone patient need amputation Female childbearing , lactate agree prevent pregnancy . Has Sepsis , Osteomyelitis Has Connective tissue disease disturbance heal wound Ex ) Rheumarthritis , systemic lupus erythematosus ( SEL ) , myalgia . The patient diagnosis Sickle sell disease Charcot 's joint . The patient stability treat chronic wasting disease . Malignant tumor history malignant disease . ( Not diagnosis complete recovery . ) The patient treat chemotherapy , radiation therapy , immunesuppressants therapy , adrenocortical hormone therapy . Although necrosis tissue remove , target ulcer heal gangrenous , necrosis tissue purulent pyorrhea . Has ulcer cardiac arrhythmia thrombus , venous insufficiency , diabetic necrobiosis lipoidic . In case use prohibit concomitant medication study . . Oral system steroid b. Immunesuppressive drug c. Unfractionated heparin infusion d. improper drug opinion investigator . Hypersensitivity applicator . ( NPWT , Silver ) The patient participate clinical trial within 30 day In opinion investigator , patient suitable participate study .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Silver dressing</keyword>
	<keyword>NPWT</keyword>
	<keyword>DMF</keyword>
	<keyword>foot</keyword>
</DOC>